1. Home
  2. TMDX vs SEZL Comparison

TMDX vs SEZL Comparison

Compare TMDX & SEZL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • SEZL
  • Stock Information
  • Founded
  • TMDX 1998
  • SEZL 2016
  • Country
  • TMDX United States
  • SEZL United States
  • Employees
  • TMDX N/A
  • SEZL N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SEZL Diversified Financial Services
  • Sector
  • TMDX Health Care
  • SEZL Finance
  • Exchange
  • TMDX Nasdaq
  • SEZL Nasdaq
  • Market Cap
  • TMDX 4.8B
  • SEZL 5.0B
  • IPO Year
  • TMDX 2019
  • SEZL N/A
  • Fundamental
  • Price
  • TMDX $120.31
  • SEZL $157.12
  • Analyst Decision
  • TMDX Buy
  • SEZL Strong Buy
  • Analyst Count
  • TMDX 9
  • SEZL 3
  • Target Price
  • TMDX $129.88
  • SEZL $108.28
  • AVG Volume (30 Days)
  • TMDX 1.0M
  • SEZL 944.4K
  • Earning Date
  • TMDX 07-30-2025
  • SEZL 08-07-2025
  • Dividend Yield
  • TMDX N/A
  • SEZL N/A
  • EPS Growth
  • TMDX N/A
  • SEZL 677.39
  • EPS
  • TMDX 1.41
  • SEZL 2.97
  • Revenue
  • TMDX $488,227,000.00
  • SEZL $329,060,890.00
  • Revenue This Year
  • TMDX $34.07
  • SEZL $66.19
  • Revenue Next Year
  • TMDX $20.76
  • SEZL $25.26
  • P/E Ratio
  • TMDX $76.58
  • SEZL $50.89
  • Revenue Growth
  • TMDX 64.43
  • SEZL 91.69
  • 52 Week Low
  • TMDX $55.00
  • SEZL $11.67
  • 52 Week High
  • TMDX $177.37
  • SEZL $186.74
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 52.35
  • SEZL 59.05
  • Support Level
  • TMDX $104.71
  • SEZL $138.52
  • Resistance Level
  • TMDX $110.00
  • SEZL $156.86
  • Average True Range (ATR)
  • TMDX 5.69
  • SEZL 9.99
  • MACD
  • TMDX 0.32
  • SEZL 0.05
  • Stochastic Oscillator
  • TMDX 74.25
  • SEZL 100.00

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About SEZL Sezzle Inc.

Sezzle Inc is a financing institution that offers technology-driven payment platform. It allows customers to split their purchase into four installments and pay over 6 weeks with only the first payment due at the time of purchase. Companies operations comprise one reportable segment, the majority of which derives revenue from payment processing platform in North America.

Share on Social Networks: